Ligand Pharmaceuticals Incorporated (LGND) M&A Call Transcript

April 27, 2026 10:01:32 am

Source: SeekingAlpha

2026-04-27 10:01:32 ET

Ligand Pharmaceuticals Incorporated (LGND) M&A Call April 27, 2026 8:00 AM EDT

Company Participants

Melanie Herman
Todd Davis - CEO & Director
Octavio Espinoza - Chief Financial Officer
Lauren Hay
...

For further details see:

Ligand Pharmaceuticals, Inc. Contingent Value Rights (Tr Beta)

0.0% G/L:

$0.075 Last:

15,035 Volume:

$0.075 Open:

Market Cap $1,377,720

Float 18,304,000

Insiders Ownership N/A

Institutions 151

Short Percent 10478%

Industry Biotechnology & Life Sciences

Sector Healthcare

Country US

City Jupiter